Lionel Ségard

Founder at QUANTUM GENOMICS

58 year

Finance

Consumer Services

Health Technology

Profile

Lionel Ségard is the founder of Quantum Genomics SA, which was founded in 2005.
He is also the founder of INSERM Transfert Initiative SAS. Mr. Ségard's current job is Chairman at Eurobiobiz SAS since 1999 and Vice Chairman at Rugby Club Massy Essonne SA since 2013.
Mr. Ségard's former job was Chief Executive Officer at INSERM Transfert SA from 2000 to 2006.
He obtained his undergraduate degree from Université de Paris XI Paris Sud.

Lionel Ségard active positions

Companies	Position	Start
QUANTUM GENOMICS	Founder	23/12/2005
Rugby Club Massy Essonne SA Rugby Club Massy Essonne SA Movies/EntertainmentConsumer Services Operates sport club	Director/Board Member	-
Eurobiobiz SAS Eurobiobiz SAS Pharmaceuticals: OtherHealth Technology Specializes in creating and developing biotechnology companies in Europe	Chairman	01/01/1999

All active positions of Lionel Ségard

Former positions of Lionel Ségard

Companies	Position	End
INSERM Transfert SA INSERM Transfert SA Investment ManagersFinance ITSA is an active private equity investment manager focused exclusively on the French biomedical sector, particularly on areas related to INSERM's medical research effort. They favor projects in fields including therapeutic agents, medical devices, diagnostics, tools and technological platforms. The firm invests between EUR 100 and 300 thousand in pre-seed and seed financing. ITSA's investment criteria include sound science, a driven management team, strong IP, a realistic business model with a clearly defined market, and a competitive milestone-driven schedule. They seek to invest in ambitious projects addressing unmet medical needs and potentially leading to dominant market positions. The firm may act as a co-founder, generally sits on the board of their portfolio companies and actively participates in their strategic decisions.	Chief Executive Officer	-
INSERM Transfert Initiative SAS INSERM Transfert Initiative SAS Investment ManagersFinance Acts as Venture Capital Fund	Founder	-

See the detail of Lionel Ségard's experience

Training of Lionel Ségard

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Lionel Ségard's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
INSERM Transfert SA INSERM Transfert SA Investment ManagersFinance ITSA is an active private equity investment manager focused exclusively on the French biomedical sector, particularly on areas related to INSERM's medical research effort. They favor projects in fields including therapeutic agents, medical devices, diagnostics, tools and technological platforms. The firm invests between EUR 100 and 300 thousand in pre-seed and seed financing. ITSA's investment criteria include sound science, a driven management team, strong IP, a realistic business model with a clearly defined market, and a competitive milestone-driven schedule. They seek to invest in ambitious projects addressing unmet medical needs and potentially leading to dominant market positions. The firm may act as a co-founder, generally sits on the board of their portfolio companies and actively participates in their strategic decisions.	Finance
Université de Paris XI Paris Sud Université de Paris XI Paris Sud Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Eurobiobiz SAS Eurobiobiz SAS Pharmaceuticals: OtherHealth Technology Specializes in creating and developing biotechnology companies in Europe	Health Technology
INSERM Transfert Initiative SAS INSERM Transfert Initiative SAS Investment ManagersFinance Acts as Venture Capital Fund	Finance
Rugby Club Massy Essonne SA Rugby Club Massy Essonne SA Movies/EntertainmentConsumer Services Operates sport club	Consumer Services
Quantum Genomics SA Quantum Genomics SA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies for cardiovascular diseases	Health Technology